Man’s aging best friend has a new treatment to dull osteoarthritis pain as the U.S. Food and Drug Administration (FDA) announced approval Friday of the first monoclonal antibody for dogs.
Called Librela, the bedinvetmab shot controls pain from the most common form of arthritis in dogs. Osteoarthritis (OA) affects about 25% of dogs during their lifetime.
In this condition, the cartilage cushion in the joints breaks down, causing bones to rub against each other. Besides pain, dogs with OA have limited joint movement, and sometimes bone spurs.